Biocogniv announced it raised $10.7 Million in an initial filing from an offering of $11.8 Million

Company

Location

About

Recent advances in artificial intelligence have enabled a new generation of companies and products that are poised to change healthcare forever. From drug discovery to early disease detection, AI is shaping a future where care is personalized, preemptive, and affordable. Biocogniv enables a key part of this future by combining laboratory medicine, state-of-the-art AI, and evidence-based acute care, to reduce preventable hospital deaths, morbidities, and cost of care.